- News & Analysis
Page 296
Allakos aligns itself with $75m IPO
Roche and Novo-backed biopharmaceutical developer Allakos has filed for a $75m initial public offering after raising more than $160m in equity funding.
Jun 27, 2018ElectroCore enters public markets with $78m offering
The Merck GHI-backed medical device developer had raised $120m in funding prior to its initial public offering.
Jun 26, 2018Cango to park itself in public markets
The online automotive retail platform is targeting $300m in an offering that will score exits for Tencent, Didi Chuxing and Taikang Life.
Jun 26, 2018Kezar kicks into public markets
Onyx Therapeutics-backed autoimmune drug developer Kezar Life Sciences has closed its initial public offering at $86.3m.
Jun 26, 2018Microsoft bonds with Bonsai
The artificial intelligence technology developer is set to be acquired by investor Microsoft in a deal that will also allow Samsung, Siemens and ABB to exit.
Jun 25, 2018Meituan Dianping makes for public markets
The local services platform, which counts Tencent as its largest investor, has filed for an offering that could net more than $4bn at a $60bn valuation.
Jun 25, 2018PayPal sinks $120m into Simility acquisition
Simility, a developer of fraud detection software, is set to be acquired by corporate investor PayPal for $120m.
Jun 25, 2018Autolus reaches $150m IPO
The UCL spinout has priced its shares at the top of its range and secured $150m in proceeds, up from its initial target of $100m.
Jun 25, 2018About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
© 2026 Mawsonia Ltd. All rights reserved.test regLogin